Lisa Ricciardi is the CEO and president of Cognition Therapeutics, a clinical-stage neuroscience company focused on neurodegenerative diseases.
Lisa Ricciardi is the CEO and president of Cognition Therapeutics, a clinical-stage neuroscience company focused on neurodegenerative diseases. She has a background in the biotech sector and owns shares in Cognition Therapeutics Inc, ContraFect Corp, and Chimerix Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library